Production of IL-1β, IL-1 Receptor Antagonist and IL-10 by Mononuclear Cells from Patients with SLE

References

• B.L. Kotzin. Systemic lupus erythematosus. Cell 1996; 85: 303–306.
   PubMedGoogle Scholar
• Fournie G.J., Circulating DNA and lupus nephritis. Kidney Int. 1988: 33:487 497.
   Google Scholar
• C.G. Cochrane and D. Koffier. Immune complex disease in experimental animals and man. Adv. Immunol. 1973; 16: 185 264.
   Google Scholar
• K. Bendtzen. Cytokines and natural regulators of cytokines. Immunol. Lett. 1994: 43: 111 123.
   Google Scholar
• W.P. Arend. Interleukin-1 receptor antagonist. Adv. Immunol. 1993: 54: 167–227.
   PubMedGoogle Scholar
• H.Y. Lan, Therapeutic effects of cytokine blockade in glomerulonephritis (editorial). Nephrol. Dial. Transplant. 1998: 13: 7–9.
   PubMedGoogle Scholar
• W.P. Arend, F.G. Joslin and R.J. Massoni. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J. Immunol. 1985: 134: 3868–3875.
   PubMedGoogle Scholar
• P.H. Schur. D.M. Chang. P. Baptiste, L.C. Uhteg and D.C. Hanson, Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals. Clin. immunol. Immunopathol. 1990; 57: 45 63.
   Google Scholar
• J.E. Salmon. R.P. Kimberly, A. Gibofsky and M. Fontino, Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor ligand binding and internalization. J. Immunol. 1984: 133: 2525 2531.
   Google Scholar
• A.l.F. Blakemore. J.K. Tarlow, M.J. Cork, C. Gordon, P. Emery and G.W. Duff, Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 1994; 37: 1380 1385.
   Google Scholar
• L. Llarente, Y. Ricliaud-Patin, J. Wijdenes, J. Alcocer-Varela, M.C. Maillot, 1. Durand-Gasselin et al.. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Nelu: 1993; 4: 421–427.
   Google Scholar
• P.D. Katsikis, C.-Q. Chu, F.M. Brennan, R.N. Maini and M. Feldmann, lmmunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 1994: 179: 1517 1527.
   Google Scholar
• E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield el al., The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum. 1982; 25: 1271–1277.
   Google Scholar
• M.H. Liang, S.A. Socher. M.G. Larson and P.H. Schur, Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989; 32: 1107 1118.
   Google Scholar
• L.S. Andersen. J. Petersen, M. Svenson and K. Bendtzen, lgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: An in vitro phenomenon depending upon plastic adherence. Autoimmunity 1995; 22: 127 133.
   Google Scholar
• D.J. Herzyk. A.E. Berger, J.N. Allen and M.D. Wewers, Sandwich ELISA formats designed to detect 17kDa IL-1/3 significantly underestimate 35kDa IL-10. J. Immunol. Methods 1992: 148: 243–254.
   PubMedGoogle Scholar
• H. Suzuki, H. Takemura and H. Kashiwagi, Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus: Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum. 1995: 38: 1055–1059.
   PubMedGoogle Scholar
• S.C. Hsieh, C.Y. Tsai, K.H. Sun, Y.Y. Tsai, ST. Tsai, S.H. Han et al., Defective spontaneous and bacterial lipopolysaccharide-stimulated production of interleukin-1 receptor antagonist by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Br. J. Rheumatol. 1995; 34: 107–112.
   Google Scholar
• G. Kaplan and G. Gaudernack, In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J. Exp. Med. 1982; 156: 1101–1114.
   Google Scholar
• S.L. Newman and M.A. Tucci, Regulation off human monocyte/macrophage function by extracellular matrix. Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function. J. Clin. Invest. 1990: 86: 703 714.
   Google Scholar
• J.E. Salmon, S. Kapur, N.L. Meryhew. O.A. Runquist and R.P. Kimberly, High-dose, pulse intravenous methyl-prednisolone enhances Fc gamma receptor-mediated mononuclear phagocyte function in systemic lupus erythematosus. Arthritis Rheum. 1989; 32: 717 725.
   Google Scholar
• M. Kavai, I. Csipo, 1. Sonkoly, J. Csongor and G.Y. Szegedi, Detective immune complex degradation by monocytes in patients with systemic lupus erythematosus. Sennd. J. Immunol. 1986: 24: 527 532.
   Google Scholar
• P. Kastnre, H. Franke, P. Kleinert, C. Gunther, K. Malberg and M. Lobnitz (Fc-receptor mediated immune complex clearance function of the mononuclear phagocyte system in systemic lupus erythematosus. Allen; Immunol. 1990; 36: 103 110.
   Google Scholar
• J. Vazquez-Doval and A. Sanchez-Ibarrola, Defective mononuclear phagocyte function in systemic lupus erythematosus: Relationship of FcRlI (CD32) with intermediate cytoskeletal filaments. J. Investig. Allcrgol. Clin. Immunol. 1993: 3: 86 91
   Google Scholar
• J.E. Salmon, R.P. Kimberly, A. Gibofsky and M. Fotino, Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fe gamma receptor specific. J. Immunol. 1986; 136: 3625–3630.
   PubMedGoogle Scholar
• T.R. Fields, E.N. Gerardi, B. Ghebrehiwet, R.S. Bennett, T.J. Lawley, R.P. Hall et al-, Reticuloendothelial system fc receptor function in rheumatoid arthritis. J. Rheumatol. 1983; 10: 550–557.
   PubMedGoogle Scholar
• M. Linker-Israeli, A.C. Bakke, R.C. Kitridou. S. Gendler, S. Gillis and D.A. Horwitz, Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 1983: 130: 2651 2655.
   Google Scholar
• R. Phillips, R. Lomnitzer and A.R. Rabson, Modulation of the sodium periodate (Nal04) response in systemic lupus erythematosus (SLE): Effect of interleukin-1 (IL-1), interleukin-2 (IL-2), phorbol myristate acetate (PMA), and indomethacin. Clin. Immunol. Immunopathol. 1985; 34: 77 83.
   Google Scholar
• S. Sierakowski, E.J. Kucharz, R.W. Lightfoot Jr. and J.S. Goodwin, Interleukin-1-production by monocytes from patients with systemic lupus erythematosus. Clin. Rheumatol. 1987:6: 403 407.
   Google Scholar
• J. Alcocer-Varela and D. Alarcon-Segovia, Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosis. Rheumatol. Int. 1995; 15: 57 63.
   Google Scholar
• P.J. Knudsen, C.A. Dinarello and T.B. Strom, Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J. Immunol. 1987; 139: 4129–4134.
   PubMedGoogle Scholar
• N. Goes, J. Urmson, V. Ramassar and P.F. Halloran, Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, inter-leukin-2, and interleukin-10. Transplantation 1995; 59: 565–572.
   Google Scholar
• R.D.W. Malefyt. J. Abrams, B. Bennett, C.G Figdor and de J.E. Vries, Interteukin 10 (1L-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of 1L-10 produced by monocytes. J. Exp. Med. 1991; 174: 1209 1220.
   Google Scholar